Latest News
Beyfortus study shows sustained reduction in infant RSV hospitalisations across two seasons
16 February 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) reported on Monday that a universal respiratory syncytial virus immunisation programme using Beyfortus (nirsevimab) was associated with a statistically signifi...
Cambridge Cognition expands into India through Ivory commercialisation agreement
16 February 2026 - Neuroscience technology company Cambridge Cognition Holdings plc (AIM: COG) has entered into a commercialisation agreement with Nostalgic Dust Private Limited, trading as Ivory, to deploy CANTAB Pathway across professional healthca...
Genentech reports positive Phase III MAJESTYdata for Gazyva in primary membranous nephropathy
16 February 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), on Monday reported positive Phase III results from the MAJESTY study evaluating Gazyva (obinutuzumab) in adults with primary membranous nep...
Ella immunoassay platform gains CE‑IVD approval in the EU
...
Advita Ortho updates Chime clinical exchange application
16 February 2026 - Medical technology company Advita Ortho announced on Friday that it has updated Chime, its clinical exchange application designed to help orthopaedic surgeons connect, collaborate and share clinical insight.Available exclusively to...